- Profile
- Personal Information
- Publications
Experts in Diabetes and Endocrinology
Holly Bates Majid Reza Sheikh Rezaee Quyen Aoh Rexford S. Ahima Joan Everett-Houser Dr. Amee K Nair Robert W. Hutchison Delaney Ivy Craig Cady  Sherley Abraham DIANN CARR John Mellem Paritosh GHOSH Tadahiro Kitamura Seiji Torii Miyuki Sato IBITORO OSAKWE Chrisoph Buettner Victoria B. Pho David E. Potter View MoreTerri Sebree
Board Member
Board of Directors
Serodus ASA
Norway
Ms. Sebree is an experienced pharmaceutical and biotechnology entrepreneur who has successfully founded, financed, grown, and taken public three biopharmaceutical companies. She is currently President of Zynerba Pharmaceuticals (Nasdaq: ZYNE) based in Devon, PA, USA. She co-founded NuPathe Inc. (Nasdaq: PATH) and served as President from February 2005 to March 2014. Prior to NuPathe, Ms. Sebree served as Senior Vice President, Development of Auxilium Pharmaceuticals (Nasdaq: AUXL) from January 2000 to January 2005. Prior to joining Auxilium, Ms. Sebree served as Executive Vice President, United States Operations at IBAH, Inc., a contract research organization. Previously, Ms. Sebree served in a variety of management roles with Abbott Laboratories for over nine years including its development head for psychopharmacology products. Ms. Sebree holds a BS from Texas A&M University
pharmaceutical sciences, entrepreneur , contract research organizations